Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $8.51 million. The enterprise value is $5.65 million.

Market Cap	8.51M
Enterprise Value	5.65M

Important Dates

The next estimated earnings date is Friday, November 21, 2025, before market open.

Earnings Date	Nov 21, 2025
Ex-Dividend Date	n/a

Share Statistics

ADXN has 111.25 million shares outstanding. The number of shares has increased by 9.98% in one year.

Current Share Class	n/a
Shares Outstanding	111.25M
Shares Change (YoY)	+9.98%
Shares Change (QoQ)	+2.21%
Owned by Insiders (%)	23.61%
Owned by Institutions (%)	2.18%
Float	39.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.45
Forward PS	n/a
PB Ratio	0.94
P/TBV Ratio	0.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	26.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.01.

Current Ratio	2.31
Quick Ratio	2.03
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-697.85

Financial Efficiency

Return on equity (ROE) is -61.91% and return on invested capital (ROIC) is -15.09%.

Return on Equity (ROE)	-61.91%
Return on Assets (ROA)	-13.55%
Return on Invested Capital (ROIC)	-15.09%
Return on Capital Employed (ROCE)	-32.72%
Revenue Per Employee	$105,174
Profits Per Employee	-$3.80M
Employee Count	2
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.79% in the last 52 weeks. The beta is 1.78, so ADXN's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	+3.79%
50-Day Moving Average	8.73
200-Day Moving Average	8.20
Relative Strength Index (RSI)	64.54
Average Volume (20 Days)	20,444

Short Selling Information

Short Interest	4,110
Short Previous Month	45,949
Short % of Shares Out	0.55%
Short % of Float	n/a
Short Ratio (days to cover)	0.07

Income Statement

In the last 12 months, ADXN had revenue of $210,347 and -$7.61 million in losses. Loss per share was -$0.08.

Revenue	210,347
Gross Profit	-620,031
Operating Income	-3.03M
Pretax Income	-7.73M
Net Income	-7.61M
EBITDA	-2.92M
EBIT	-3.03M
Loss Per Share	-$0.08

Balance Sheet

The company has $2.89 million in cash and $48,269 in debt, giving a net cash position of $2.85 million or $0.03 per share.

Cash & Cash Equivalents	2.89M
Total Debt	48,269
Net Cash	2.85M
Net Cash Per Share	$0.03
Equity (Book Value)	9.07M
Book Value Per Share	0.08
Working Capital	1.90M

Cash Flow

In the last 12 months, operating cash flow was -$1.81 million and capital expenditures -$1,601, giving a free cash flow of -$1.82 million.

Operating Cash Flow	-1.81M
Capital Expenditures	-1,601
Free Cash Flow	-1.82M
FCF Per Share	-$0.02

Margins

Gross Margin	-294.77%
Operating Margin	-1,438.85%
Pretax Margin	-3,675.87%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.98%
Shareholder Yield	-9.98%
Earnings Yield	-89.40%
FCF Yield	-21.35%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

ADXN has an Altman Z-Score of -56.56 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-56.56
Piotroski F-Score	1